Profiles for companies starting with 'v'
✉ Email this page to a colleague
Drugs and US Patents for v
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verastem Inc | AVMAPKI FAKZYNJA CO-PACK (COPACKAGED) | avutometinib potassium; defactinib hydrochloride | CAPSULE, TABLET;ORAL | 219616-001 | May 8, 2025 | RX | Yes | Yes | 7,928,109 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-001 | Jul 17, 2012 | AB | RX | Yes | No | 8,895,057 | ⤷ Start Trial | ⤷ Start Trial | |||
| Vanda Pharms Inc | PONVORY | ponesimod | TABLET;ORAL | 213498-003 | Mar 18, 2021 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Vertex Pharms Inc | SYMDEKO (COPACKAGED) | ivacaftor; ivacaftor, tezacaftor | TABLET;ORAL | 210491-002 | Jun 21, 2019 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Vivus Llc | QSYMIA | phentermine hydrochloride; topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 022580-002 | Jul 17, 2012 | AB | RX | Yes | No | 9,011,906 | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
